TrialAmerican journal of clinical dermatology2026

Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies.

Maryanne Senna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.